✦ LIBER ✦

Prevalance of hepatitis C virus (HCV) antibody in cancer patients (PTS) from Turkey

✍ Scribed by Topeli, A; Ozyilkan, O; Ozyilkan, E; Kars, A; Tekuzman, G; Baltali, E; Ozkuyumcu, C; Kayhan, B; Telatar, H; Firat, D

Book ID: 123468348
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 148 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91308-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis “C” virus antibody (anti-HCV)

Hepatitis “C” virus antibody (anti-HCV) prevalence in psoriasis

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Prevalence of antibodies to hepatitis C

Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs

✍ Schramm, W. ;Roggendorf, M. ;Rommel, F. ;Kammerer, R. ;Pohlmann, H. ;Ra�hofer, R 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 259 KB

High prevalence of antibodies to hepatit

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies

✍ Jean-François Quaranta; Albert Tran; Daniel Régnier; Rémi Letestu; Christine Beu 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Prevalence of hepatitis G virus (HGV) in

Prevalence of hepatitis G virus (HGV) in cancer patients in Turkey

✍ Ö. Özyilkan; Y. Elgin; Ş. Çakir; A. Bedir; E. Özyilkan; M. Günaydin 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Hepatitis C-virus (HCV) antibodies in pa

Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation

✍ P. Baur; V. Daniel; S. Pomer; H. Scheurlen; G. Opelz; D. Roelcke 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 565 KB

Prevalence of antibody to hepatitis C vi

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice seroco cohort)

✍ J. F. Quaranta; S. R. Delaney; S. Alleman; J. P. Cassuto; P. Dellamonica; J. P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

## Abstract The prevalence of antibody to hepatitis C virus (HCV) in a cohort of 272 HIV‐infected patients was assessed by means of 4 anti‐HCV assays: a 1st generation and a neutralization test, a 2nd generation test, and a confirmatory test, the dot‐blot Matrix HCV™ immunoassay. The cohort include